Potential for improved survival with intensification of daunorubicin based induction chemotherapy in acute myeloid leukemia patients who do not receive transplant: A multicenter retrospective study
published in: Leukemia Research
date of publication: 2015-05-02
main subject: multicenter clinical trial, acute myeloid leukemia, daunorubicin
Cites articles
There is nothing here
Article - wd:Q41692461